{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,4]],"date-time":"2022-04-04T15:16:28Z","timestamp":1649085388567},"reference-count":19,"publisher":"Spandidos Publications","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["mol clin onc"],"DOI":"10.3892\/mco.2017.1447","type":"journal-article","created":{"date-parts":[[2017,10,10]],"date-time":"2017-10-10T08:07:37Z","timestamp":1507622857000},"source":"Crossref","is-referenced-by-count":0,"title":["Development of fever following first administration of\u00ef\u00bf\u00bdzoledronate as a prognostic factor in advanced non\u2011small cell lung cancer patients with bone metastases"],"prefix":"10.3892","author":[{"given":"Hiroki","family":"Izumi","sequence":"first","affiliation":[{"name":"Division of Medical Oncology and Molecular Respirology, Faculty of Medicine, Tottori University, Yonago, Tottori 683\u20118504, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tadashi","family":"Igishi","sequence":"additional","affiliation":[{"name":"Division of Medical Oncology and Molecular Respirology, Faculty of Medicine, Tottori University, Yonago, Tottori 683\u20118504, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akira","family":"Yamasaki","sequence":"additional","affiliation":[{"name":"Division of Medical Oncology and Molecular Respirology, Faculty of Medicine, Tottori University, Yonago, Tottori 683\u20118504, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kennichi","family":"Takeda","sequence":"additional","affiliation":[{"name":"Division of Medical Oncology and Molecular Respirology, Faculty of Medicine, Tottori University, Yonago, Tottori 683\u20118504, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaaki","family":"Yanai","sequence":"additional","affiliation":[{"name":"Division of Medical Oncology and Molecular Respirology, Faculty of Medicine, Tottori University, Yonago, Tottori 683\u20118504, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natsumi","family":"Tanaka","sequence":"additional","affiliation":[{"name":"Division of Medical Oncology and Molecular Respirology, Faculty of Medicine, Tottori University, Yonago, Tottori 683\u20118504, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomohiro","family":"Sakamoto","sequence":"additional","affiliation":[{"name":"Division of Medical Oncology and Molecular Respirology, Faculty of Medicine, Tottori University, Yonago, Tottori 683\u20118504, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shizuka","family":"Nishii\u2011Ito","sequence":"additional","affiliation":[{"name":"Division of Medical Oncology and Molecular Respirology, Faculty of Medicine, Tottori University, Yonago, Tottori 683\u20118504, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirokazu","family":"Touge","sequence":"additional","affiliation":[{"name":"Division of Medical Oncology and Molecular Respirology, Faculty of Medicine, Tottori University, Yonago, Tottori 683\u20118504, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiro","family":"Kodani","sequence":"additional","affiliation":[{"name":"Division of Medical Oncology and Molecular Respirology, Faculty of Medicine, Tottori University, Yonago, Tottori 683\u20118504, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shingo","family":"Matsumoto","sequence":"additional","affiliation":[{"name":"Division of Medical Oncology and Molecular Respirology, Faculty of Medicine, Tottori University, Yonago, Tottori 683\u20118504, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuji","family":"Kawasaki","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Tsuyama First Hospital, Nakashima, Tsuyama 708\u20110871, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eiji","family":"Shimizu","sequence":"additional","affiliation":[{"name":"Division of Medical Oncology and Molecular Respirology, Faculty of Medicine, Tottori University, Yonago, Tottori 683\u20118504, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2017,10,10]]},"reference":[{"key":"key20200713201452_b1-mco-0-0-1447","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3322\/caac.20138","article-title":"Cancer statistics, 2012","volume":"62","author":"Siegel","year":"2012","journal-title":"CA Cancer J Clin"},{"key":"key20200713201452_b2-mco-0-0-1447","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1053\/ctrv.2000.0210","article-title":"Metastatic bone disease: Clinical features, pathophysiology and treatment strategies","volume":"27","author":"Coleman","year":"2001","journal-title":"Cancer Treat Rev"},{"key":"key20200713201452_b3-mco-0-0-1447","first-page":"215","article-title":"Phase III clinical study of zoledronic acid in the treatment of pain induced by bone metastasis from solid tumor or multiple myeloma","volume":"30","author":"Dong","year":"2008","journal-title":"Zhonghua Zhong Liu Za Zhi"},{"key":"key20200713201452_b4-mco-0-0-1447","doi-asserted-by":"publisher","first-page":"3150","DOI":"10.1200\/JCO.2003.04.105","article-title":"Zoledronic acid versus placebo in the treatment of skeletal metastases in patients with lung cancer and other solid tumors: A phase III, double-blind, randomized trial-the Zoledronic Acid Lung Cancer and Other Solid Tumors Study Group","volume":"21","author":"Rosen","year":"2003","journal-title":"J Clin Oncol"},{"key":"key20200713201452_b5-mco-0-0-1447","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1182\/blood.V96.2.384","article-title":"Stimulation of gammadelta T cells by aminobisphosphonates and induction of antiplasma cell activity in multiple myeloma","volume":"96","author":"Kunzmann","year":"2000","journal-title":"Blood"},{"key":"key20200713201452_b6-mco-0-0-1447","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/S1470-2045(11)70122-X","article-title":"Adjuvant endocrine therapy plus zoledronic acid in premenopausal women with early-stage breast cancer: 62-month follow-up from the ABCSG-12 randomised trial","volume":"12","author":"Gnant","year":"2011","journal-title":"Lancet Oncol"},{"key":"key20200713201452_b7-mco-0-0-1447","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1007\/BF02698044","article-title":"Antitumor effect of zoledronic acid in previously untreated patients with multiple myeloma","volume":"24","author":"Avil\u00e9s","year":"2007","journal-title":"Med Oncol"},{"key":"key20200713201452_b8-mco-0-0-1447","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1056\/NEJM199903043400914","article-title":"Gamma\/delta T-cell stimulation by pamidronate","volume":"340","author":"Kunzmann","year":"1999","journal-title":"N Engl J Med"},{"key":"key20200713201452_b9-mco-0-0-1447","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1089\/107999003322558782","article-title":"Fever after zoledronic acid administration is due to increase in TNF-alpha and IL-6","volume":"23","author":"Dicuonzo","year":"2003","journal-title":"J Interferon Cytokine Res"},{"key":"key20200713201452_b10-mco-0-0-1447","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/j.coi.2006.07.002","article-title":"Human Vgamma9Vdelta2 T cells: Promising new leads for immunotherapy of infections and tumors","volume":"18","author":"Bonneville","year":"2006","journal-title":"Curr Opin Immunol"},{"key":"key20200713201452_b11-mco-0-0-1447","doi-asserted-by":"publisher","first-page":"4380","DOI":"10.1210\/jc.2010-0597","article-title":"Characterization of and risk factors for the acute-phase response after zoledronic acid","volume":"95","author":"Reid","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"key20200713201452_b12-mco-0-0-1447","doi-asserted-by":"publisher","first-page":"469","DOI":"10.5761\/atcs.oa.10.01637","article-title":"Female gender is an independent prognostic factor in non-small-cell lung cancer: A meta-analysis","volume":"17","author":"Nakamura","year":"2011","journal-title":"Ann Thorac Cardiovasc Surg"},{"key":"key20200713201452_b13-mco-0-0-1447","first-page":"1998","article-title":"NIH Public Access","volume":"311","author":"Kris","year":"2014","journal-title":"Select Target Drugs"},{"key":"key20200713201452_b14-mco-0-0-1447","doi-asserted-by":"publisher","first-page":"2513","DOI":"10.1200\/JCO.2005.00.992","article-title":"Mutations of the epidermal growth factor receptor gene predict prolonged survival after gefitinib treatment in patients with non-small-cell lung cancer with postoperative recurrence","volume":"23","author":"Mitsudomi","year":"2005","journal-title":"J Clin Oncol"},{"key":"key20200713201452_b15-mco-0-0-1447","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/0167-5699(89)90321-6","article-title":"Subpopulations of human peripheral T gamma delta lymphocytes","volume":"10","author":"Triebel","year":"1989","journal-title":"Immunol Today"},{"key":"key20200713201452_b16-mco-0-0-1447","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1080\/14653240802419328","article-title":"Zoledronate facilitates large-scale ex vivo expansion of functional gammadelta T cells from cancer patients for use in adoptive immunotherapy","volume":"10","author":"Kondo","year":"2008","journal-title":"Cytotherapy"},{"key":"key20200713201452_b17-mco-0-0-1447","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1097\/CJI.0b013e318207ecfb","article-title":"Adoptive immunotherapy for advanced non-small cell lung cancer using zoledronate-expanded \u03b3\u03b4Tcells: A phase I clinical study","volume":"34","author":"Sakamoto","year":"2011","journal-title":"J Immunother"},{"key":"key20200713201452_b18-mco-0-0-1447","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1007\/s00262-011-1021-7","article-title":"Phase I\/II study of adoptive transfer of \u03b3\u03b4 T cells in combination with zoledronic acid and IL-2 to patients with advanced renal cell carcinoma","volume":"60","author":"Kobayashi","year":"2011","journal-title":"Cancer Immunol Immunother"},{"key":"key20200713201452_b19-mco-0-0-1447","doi-asserted-by":"publisher","first-page":"40","DOI":"10.3390\/ph8010040","article-title":"\u03b3\u03b4 T cell immunotherapy-A review","volume":"8","author":"Kobayashi","year":"2015","journal-title":"Pharmaceuticals (Basel)"}],"container-title":["Molecular and Clinical Oncology"],"original-title":[],"deposited":{"date-parts":[[2020,7,13]],"date-time":"2020-07-13T19:14:59Z","timestamp":1594667699000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/mco.2017.1447"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10,10]]},"references-count":19,"URL":"https:\/\/doi.org\/10.3892\/mco.2017.1447","relation":{},"ISSN":["2049-9450","2049-9469"],"issn-type":[{"value":"2049-9450","type":"print"},{"value":"2049-9469","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,10,10]]}}}